Life Scientist > Life Sciences

No evidence that depression is caused by low serotonin: review

01 August, 2022

The umbrella review suggests that depression is not likely caused by a chemical imbalance, and calls into question what antidepressants do.


Fast method to determine antibiotic effectiveness

28 July, 2022

The method can both detect the presence of a bacterial infection and determine which antibiotics will be most effective for treatment in less than five hours.


Alcohol, high-fat diet linked with cognitive decline

28 July, 2022

Cognitive decline has been observed in mice fed a high-fat diet, while moderate consumption of alcohol is associated with higher iron levels in the human brain.


How cell biology contributes to brain disorders

21 July, 2022

An international team of scientists has discovered that cells in the brain differ in very fundamental ways from those in other body tissues.


Boosting iNKT cells improves blood cancer immunotherapy

19 July, 2022

iNKT cells are scarce in the body, and numbers are even lower in cancer patients, but they can be boosted using a relatively straightforward vaccine approach.


Stomach stem cells switch function upon injury

15 July, 2022

A stomach adult stem cell population can fulfil two distinct functions: either help with digestion under normal conditions or take the lead on injury response.


The early embryo is more in control than we thought

14 July, 2022

The early embryo invests in its own future: it promotes the formation of the tissues that will soon take care of its development.


Menopause, reproductive factors affect dementia risk

13 July, 2022

Postmenopausal women may have more of a brain biomarker called white matter hyperintensities, linked to cognitive decline, than premenopausal women or men of the same age.


Probiotics can help to tackle depression

12 July, 2022

Researchers have shown that probiotics can support the effect of antidepressants and help to alleviate depression.


Fourth COVID-19 vaccine now available for those aged 30+

08 July, 2022 by Lauren Davis

ATAGI has recommended that people aged 50 to 64 years should have their fourth dose, while people aged 30 to 49 years may choose to have a fourth shot if they wish.


New drug target identified for COPD

06 July, 2022

Researchers discovered elevated CMA1 levels in the lung tissues of patients with severe chronic obstructive pulmonary disease (COPD).


How food triggers an inflammatory response in the brain

05 July, 2022

Even before carbohydrates reach the bloodstream, the very sight and smell of a meal trigger the release of insulin.


Eye-opening biomarkers for autism and ADHD discovered

30 June, 2022

Recordings from the retina can identify distinct signals for both ADHD and ASD, providing a potential biomarker for each condition.


Fine-tuning CAR T cell therapy to reduce side effects

29 June, 2022

Researchers fine-tuned the cells used in immunotherapy so that their activity is strong enough to eliminate cancer but not so strong that they generate toxic side effects.


Newly discovered 'giant' bacterium visible to the naked eye

24 June, 2022 by Lauren Davis

Thiomargarita magnifica is larger than all other known giant bacteria by ~50-fold, and is thus visible without a microscope.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd